Strategic Focus Potential clients are biopharma and medical device companies seeking reimbursement strategy, market access, and regulatory guidance in the US. Engage on services around CMS/FDA reimbursement, healthcare reform impact analyses, and strategic planning to support commercialization efforts.

Alliance & Licensing Recent licensing collaboration with Esperovax indicates openness to exclusive partnerships and joint manufacturing initiatives. Target fast-moving vaccine or biologics players exploring novel manufacturing methods and strategic licensing deals.

Leadership Expansion Leadership appointments in medical affairs, operations, and market access signal capacity to scale advisory services. Sales opportunities exist in offering expanded advisory packages, program management, and integration with client teams.

US Market Access Strong emphasis on US reimbursement and policy navigation suggests a value proposition for early-stage and mid-stage companies seeking to streamline payer strategies, pricing, and payer communications to accelerate market entry.

Tech-Enabled Services Utilizes cloud-based and collaboration tools (Google Cloud, Microsoft OneNote, PHP) to support project delivery. Present a differentiated offering with scalable, technology-enabled consulting workflows and transparent engagement dashboards for clients.